D. E. Shaw & Co., Inc. Inogen Inc Transaction History
D. E. Shaw & Co., Inc.
- $98.6 Billion
- Q2 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Inogen Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 155,486 shares of INGN stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
155,486
Previous 131,744
18.02%
Holding current value
$1.82 Million
Previous $1.06 Million
18.91%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding INGN
# of Institutions
136Shares Held
22.1MCall Options Held
122KPut Options Held
35.4K-
Divisadero Street Capital Management, LP Miami, FL2.35MShares$27.5 Million3.29% of portfolio
-
Camber Capital Management LP Boston, MA2MShares$23.4 Million0.45% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.95MShares$22.8 Million0.33% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$19.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$16.8 Million0.0% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $268M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...